Weight-loss drugs linked to rare vision loss: Harvard study [itvJ5Trkt3f]

Weight-loss drugs linked to rare vision loss: Harvard study [itvJ5Trkt3f]

| 1h 28m 28s | Video has closed captioning.

Novo Nordisk (NVO) and Eli Lilly (LLY) shares dip in reaction to a Harvard study that found GLP-1 weight-loss drugs Ozempic and Wegovy could be linked to rare cases of vision loss. Yahoo Finance health reporter Anjalee Khemlani explains the study's findings. About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage your financial life. - Get the latest news and data at finance.yahoo.com - Download the Yahoo Finance app on Apple (or Android ( - Follow Yahoo Finance on social: X: Instagram: TikTok: Facebook: LinkedIn: #weightloss #yahoofinance #glp1